In Reply “As Few as Three Months of Preoperative Semaglutide Exposure Prior to Total Knee Arthroplasty Is Associated With Reduced Postoperative Adverse Events in Patients Who Have Type II Diabetes”
Seddio A, Grauer J, Rubin L. In Reply “As Few as Three Months of Preoperative Semaglutide Exposure Prior to Total Knee Arthroplasty Is Associated With Reduced Postoperative Adverse Events in Patients Who Have Type II Diabetes”. The Journal Of Arthroplasty 2026, 41: e3-e4. PMID: 41371804, DOI: 10.1016/j.arth.2025.09.029.Peer-Reviewed Original Research